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Background: Pancreatic fistula (PF) remains the most challenging complication after pancreaticoduodenectomy
(PD). The purpose of this study was to identify the risk factors of PF and delineate its impact on patient outcomes.
Methods: We retrospectively reviewed clinical data of 532 patients who underwent PD and divided them into PF
group and no PF group. Risk factors and outcomes of PF following PD were examined.
Results: PF was found in 65 (12.2%) cases, of whom 11 were classified into ISGPF grade A, 42 grade B, and 12
grade C. Clinically serious postoperative complications in the PF versus no PF group were mortality, abdominal
bleeding, bile leak, intra-abdominal abscess and pneumonia. Univariate and multivariate analysis showed that blood
loss ≥ 500 ml, pancreatic duct diameter≤ 3 mm and pancreaticojejunostomy type were independent risk factors of
PF after PD.
Conclusions: Blood loss ≥ 500 ml, pancreatic duct diameter ≤ 3 mm and pancreatico-jejunostomy type were
independent risk factors of PF after PD. PF was related with higher mortality rate, longer hospital stay, and other
complications.
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Pancreaticoduodenectomy (PD) is the classic surgical
approach for both malignant and benign disease of
pancreatic head, duodenum and periampullary region.
PD was associated with high mortality and morbidity
since introduced as a treatment approach. Recently,
both the mortality and morbidity following PD were
significantly reduced for the improvement of surgical
skills and perioperative care. The mortality rate after
PD was kept even as low as 5% in many specialized
centers [1-4]. Although the mortality following PD has
decreased, the morbidity rate remains at a high level
[1,4,5], with pancreatic fistula (PF) as the most challenging
complication. Risk factors for PF after PD described in the* Correspondence: pengbaogang1963@163.com
†Equal contributors
1Department of Hepatobiliary Surgery, the First Affiliated Hospital, Sun
Yat-sen University, Guangzhou 510080, PR China
Full list of author information is available at the end of the article
© 2015 Fu et al.; licensee BioMed Central. This
Attribution License (http://creativecommons.o
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.literature included patient demographics, diameter of pan-
creatic duct, pancreatic texture and anastomotic tech-
nique [5-8]. Generally, PF is correlated with other major
complications such as intraperitoneal bleeding, abdominal
abscess, delayed gastric emptying and wound infection, all
of which prolong the hospital stays and increase health-
care costs [6-8].
To identify patients at high risk for PF and avoid the
accompanying complications, it is important to predict
its occurrence so that prompt treatment can be adminis-
tered. The purpose of this study was to analyze the risk
factors and outcomes of PF from a prospective database
of 532 patients undergoing PD.Methods
Five hundred thirty-two patients undergoing elective PD
in the first Affiliated Hospital of Sun Yat-sen University
between April 2000 and November 2011 were included
in this study. Clinical data including demographics,is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Fu et al. BMC Surgery  (2015) 15:34 Page 2 of 6intraoperative procedures and postoperative complica-
tions were reviewed. Prior approval from the commit-
tee for Ethical Review of research involving Human
Subject of the first Affiliated Hospital of Sun Yat-sen
University (Guangzhou, China) and informed consent
from patients were obtained before study. One hun-
dred and forty-one patients (26.5%, 141/532) accepted
preoperative biliary drainage.
All patients were divided into 2 groups, according to the
presence of PF or not: PF group and no PF group. PF, de-
layed gastric emptying (DGE), and post-pancreatectomy
hemorrhage (PPH) were defined according to the Inter-
national Study Group on Pancreatic Fistula (ISGF) [9-11].
Bile leak was diagnosed based on the following criteria: (1)
bile fluid in the peritoneal drainage or oozing from the
wound; or (2) radiographically proven fluid collection
requiring percutaneous drainage and demonstrating ele-
vated bilirubin levels [12,13]. The operative mortality was
defined as death within 30 days after operation or before
discharge from the hospital (irrespective of the duration of
stay). Other morbidities were defined as any of the follow-
ing: intraabdominal abscess (IAA) (drainage from an intra-
operatively placed drain with positive cultures requiring
the placement of a new percutaneous drain or operative
intervention); pneumonia (fever, leukocytosis, culture-
positive sputum with polymorphonuclear leukocytes
on Gram stain, and chest radiograph demonstrating
focal infiltrates); wound infection (purulent drainage
from the postoperative wound, requiring opening and
packing of the wound), deep venous thrombosis (charac-
teristic venous obstruction, demonstrated on Doppler
ultrasound), chyle leak (milky drainage from the periton-
eal drain) [13]. Postoperative complications were graded
according to Clavien-Dindo classification [5].
Surgical technique
Of the 532 patients, 7 cases had a pylorus-preserving
pancreaticoduodenectomy (PPPD) and the others had a
classical pancreaticoduodenectomy (PD). The pancreatico-
jejunostomy was performed using a traditional 2-layer anas-
tomosis (n = 304), an invaginated anastomosis (n = 125),
and a duct-mucous anastamosis (n = 103) based on sur-
geon’s preference. No pancreaticogastrostomy was used in
our study. Four hundred and seventeen anastomoses
(78.4%) were constructed using pancreatic duct stents.
The biliary stent was not routinely placed. Drains were
placed routinely in the Winslow’s foramen for draining
peritoneal fluid in all patients. Prophylactic octreotide or
somatostatin was not routinely used.
Statistical analysis
All statistical analyses were performed with SPSS version
21.0 software (IBM, USA). Quantitative data are expressed
as mean ± SD. Independent sample Student’s t test wasused to compare continuous variables. The Chi-square
test or Fisher exact test was used to compare categorical
variables. Of all the variables tested in univariate analysis,
only those with P < .05 were put into multivariate analysis.
Logistic regression (forward selection) was performed to
determine the independent risk factors of PF. P < .05 was
considered statistically significant.
Results
Incidence of pancreatic fistula
The indications for PD included duodenal neoplasm,
pancreatic cancer, bile duct neoplasm, ampullary neo-
plasm, chronic pancreatitis, gastric antrum cancer,
cystadenoma, pancreatic cyst, and so on. Three major
indications for PD were duodenal neoplasm in 164 pa-
tients (30.8%), pancreatic cancer in 140 patients (26.3%)
and ampullary neoplasm in 102 patients (19.2%). Sixty-
five patients (12.2%) developed PF after PD, A grade 11
cases (16.9%, 11/65), B grade 42 cases (64.6%, 42/65)
and C grade 12 cases (18.5%, 12/65).
Risk factors of pancreatic fistula
Fourteen clinical factors of PF were compared between
the PF group and the no PF group by univariate analysis.
We found that blood loss ≥ 500 ml, pancreatic duct
diameter ≤ 3 mm and pancreaticojejunostomy type had
statistical significance. Multivariate logistic regression
analysis was used to identify the independent risk factors
of PF. We identified that blood loss ≥ 500 ml (hazard ratio
[HR] = 2.281; 95% confidence interval [CI] 1.334-3.901;
P = .003), pancreatic duct diameter ≤ 3 mm (HR = 0.351;
95%CI, 0.192-0.641; P = .001) and pancreaticojejunost-
omy type (HR = 1.355; 95%CI, 1.007-1.823; P = .045)
were independent risk factors for PF after PD (Table 1).
Postoperative outcomes
A total of 303 (57.0%, 303/532) patients didn’t develop
any complication, while 229 (43.0%, 229/532) patients had
at least one complication: 60 (11.3%, 60/532) patients had
grade Icomplications, 50 (9.4%, 50/532) patients had grade
II complications, 93 (17.5%, 93/532) patients had grade III
complications, 3 (0.6%, 3/532)patients had grade IV com-
plications. Grade V (death) occurred in 23 patients (4.3%,
23/532). Besides PF, other postoperative complications in-
cluded PPH (60/532, 11.3%), bile leak (17/532, 3.2%), de-
layed gastric emptying (18/532, 3.4%), intraabdominal
abscess (IAA) (97/532, 18.2%), pneumonia (27/532, 5.1%),
wound infection (88/532, 16.5%), deep venous thrombosis
(DVT) (1/532, 0.2%) and chyle leak (2/532, 0.4%). Mortal-
ity, IAB, bile leak, IAA and pneumonia were significantly
higher in the PF group when compared with the no PF
group. The length of hospital stay significantly increased
in those patients who developed PF compared with those
that did not (Table 2).
Table 1 Risk factors of pancreatic fistula by univariate and multivariate analysis
Variable PF group NPF group t/X2 P HR 95% CI P
Total 65 467
Preoperative factors
Age (years) 58.09 ± 11.50 55.48 ± 12.10 1.640 0.102
Gender
Male 46(70.8%) 298(63.8%)
Female 19(29.2%) 169(36.2%) 1.209 0.272
Hemoglobin serum levels (g/L) 117.85 ± 24.05 120.03 ± 20.86 0.696 0.487
Albumin 0.075 0.784
<35 g/L 9(13.8%) 59(12.6% )











Operative time(min) 378.15 + 91.36 356.97 + 84.87 1.868 0.062
Blood loss 0.075 0.784
<500 ml 28(43.1%) 293(62.7%) 9.219 0.002 2.281 1.334-3.901 0.003
≥500 ml 37(56.9%) 174(37.3%)
Pancreatic texture 2.064 0.151
Soft 54(83.1%) 350(74.9%)
Firm 11(16.9%) 117(25.1%)
Diameter of pancreatic duct 14.643 <0.001 0.351 0.192-0.641 0.001
≤3 mm 49(75.4%) 234(50.1%)
>3 mm 16(24.6%) 233(49.9%)
Pancreatic stent 0.435 0.510
Yes 53(81.5%) 364(77.9%)
No 12(18.2%) 103(22.1%)
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Table 1 Risk factors of pancreatic fistula by univariate and multivariate analysis (Continued)
Diameter of pancreatic duct 14.643 <0.001 0.351 0.192-0.641 0.001
≤3 mm 49(75.4%) 234(50.1%)
>3 mm 16(24.6%) 233(49.9%)
Pancreatic stent 0.435 0.510
Yes 53(81.5%) 364(77.9%)
No 12(18.2%) 103(22.1%)
Venous resection 1.095 0.295
Yes 3(4.6%) 39(8.4%)
No 62(95.4%) 428(91.6%)
PJ types 15.992 <0.001 1.355 1.007-1.823 0.045
Traditional 2-layers anastomosis 33(50.8%) 271(58.0%)
Invaginated anastomosis 27(41.5%) 98(21.0%)
Duct to mucous anastomosis 5(7.7%) 98(21.0%)
PF: pancreatic fistula; NPF: non pancreatic fistula; PJ: pancreaticojejunostomy; HR: hazard ratio; CI: confidence interval.
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PF is the most challenging complication after PD. Be-
cause it was associated with substantial mortality and
morbidity, some authors even defined it as an “Achilles
heel” of PD [6]. Our results demonstrate that the inci-
dence of PF after PD was about 12.0%, which appears to
be comparable to the PF rate of 9–14% reported in other
specialized centers [14-17].
The formation of PF is associated with many variables
involving demographic, preoperative, intraoperative and
pathological factors. Previous studies had reported that
pancreaticogastrostomy was associated with significantly
lower pancreatic fistula rate than pancreaticojejunost-
omy. Pancreaticogastrostomy was more efficient than
pancreatico-jejunostomy in reducing the incidence of
postoperative pancreatic fistula [18-23]. In our institution,Table 2 Postoperative outcomes between the two groups
Outcomes PF group (n = 65)
Mortality 7/58(10.8%)











LOS: length of stay; DGE: delayed gastric emptying; IAA: intraabdominal abscess; DVwe have not performed pancreaticogastrostomy after PD
so far. There is still a controversy in the relationship be-
tween preoperative biliary drainage and the incidence of
PF. A study from Hopkins suggested that preoperative
stent was associated with high incidence of postoperative
pancreatic fistula [24]. Schmidt et al. also showed that
those patients who had preoperative percutaneous trans-
hepatic biliary (PTB) stent showed an increased risk of PF
formation [6]. However, Aranha et al. found that no differ-
ence in the incidence of PF versus no-PF in those patients
having ERCP or PTC and an increase in PF in those pa-
tients who did not have preoperative stents compared
with those patients who did [8]. Lin et al. indicated that
no difference in the incidence of PF versus no-PF in those
patients having preoperative stent (either endoscopic or
PBD) [14]. Our results also showed that there was noNPF group n = 467 t/X2 P
16/451(3.4%) 7.438 0.006











T: deep venous thrombosis; Other abbreviations as in Table 1.
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postoperative PF.
As expected, increased intraoperative blood loss ap-
peared to be an important risk factor of PF. Yeh et al.
demonstrated increased intraoperative blood loss was an
independent risk factor for PF after PD by univariate
and multivariate analysis [25]. The factors which might
increase blood loss during operation included a more
advanced stage of the disease such as portal vein inva-
sion or superior mesenteric vein, adhesions due to prior
operations, jaundice-associated coagulopathy, obesity,
and concurrent pancreatitis [25]. In our study, Intraop-
erative blood loss exceeding 500 ml occurred in 39.7%
(211 of 532 patients) of patients, and of those, 17.5%
patients (37/211) developed PF, which was signifi-
cantly higher than patients with blood loss less than
500 ml (28/321, 8.7%). Again, our results showed
blood loss ≥ 500 ml (hazard ratio [HR] = 2.281; 95%
confidence interval [CI] 1.334-3.901; P = .003) was an
independent risk factor for PF after PD. Kawai et al.
showed that the preoperative CT image-assessed
ligation of inferior pancreaticoduodenal artery (IPDA)
method (CLIP) was a useful and reliable operative
technique for reducing intraoperative bleeding in PD
[26]. Ishizaki et al. reported early ligation of the in-
ferior pancreatoduodenal artery (IPDA) not only re-
duced intraoperative blood loss during PD but also
alleviated postoperative morbidity and mortality [27].
Therefore, IPDA method was suggested to decrease
intraoperative bleeding.
Type of pancreaticojejunostomy anastomosis has also
been cited as a predictor of PF after PD. Berger et al. re-
ported considerably fewer fistulas with invagination
compared with duct to mucosapancreaticojejunostomy
after pancreaticoduodenectomy by a randomized, pro-
spective, dual-institution trial [28]. However, Schmidt
et al. and Bartoli et al. reported that lowest incidence of
PF in patients who had a duct to mucous anastomosis
than other anastomoses [6,29]. We also found that the
lowest incidence of PF in patients who had a duct to
mucous anastomosis (4.9%) versus a traditional 2-layers
pancreaticojejunostomy (10.9%) or an invaginated pan-
creaticojejunostomy (21.6%) (P < .001). Since the diam-
eter of major pancreatic duct played an important role
in selection of PJ types, some studies have concluded
that major pancreatic duct diameter was also an inde-
pendent risk factor of PF after PD [4,23]. Generally, the
narrowed pancreatic duct diameter is not only more
challenging to reconstruct, but also more likely to either
occlude or dehisce. In our study, we found that PF in pa-
tients who had pancreatic duct diameter > 3 mm (6.4%)
was significantly lower than those who had pancreatic
duct diameter ≤ 3 mm (17.3%) (P < .001). Soft pancreatic
tissue has been regarded as a potent contributor for PFformation [4,7,14], while it had no effect on PF in our
study. Based on our results and literatures, we think we
should try to adopt duct to mucous anastomosis when
the pancreatic duct diameter > 3 mm. If the pancreatic
duct diameter measured 3 mm or less, we can expand
the pancreatic duct by placing a fine stay suture in the
middle of the anterior wall of the pancreatic duct as de-
scribed by Hatori [30] and performed pancreaticojeju-
nostomy with duct-to-mucosa anastomosis without a
stent tube [31].
PF is associated with a greater many of other compli-
cations and prolonged hospital stay [6,8,14,28]. In our
study, it was found to be associated with mortality, ab-
dominal bleeding, bile leakage, intraabdominal abscess,
pneumonia, reoperations and long hospital stay. Other
complications including gastrointestinal bleeding, de-
layed gastric emptying, wound infection, deep venous
thrombosis (DVT) and chyle leak were not significant
when the PF group was compared with the no PF group.
Conclusions
In conclusion, blood loss and the pancreatic duct diam-
eter and pancreaticojejunostomy type were independent
risk factors for PF after PD. Outcomes in patients with
PF were remarkable for a higher rate of mortality, ab-
dominal bleeding and septic complications, an increased
incidence of reoperations, and a longer hospital stay.
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